Volume 127, Issue 2

Search all Journal of Neural Transmission articles

February 2020

Special Issue: Current aspects of neuropsychiatry: An appreciation of Prof. Dr. Moussa B.H. Youdim on the occasion of his 80th birthday

Issue Editor:

Peter Riederer

20 articles in this issue

Prof. Dr. Moussa B.H. Youdim: an appreciation on the occasion of his 80th birthday
Peter Riederer
Editorial 03 February 2020 Pages: 117 - 118
Ted Sourkes, Moussa Youdim and I
A. Claudio Cuello
Neurology and Preclinical Neurological Studies - Review Article 18 January 2020 Pages: 119 - 123
The discovery and development of rasagiline as a new anti-Parkinson medication
John P. M. Finberg
Neurology and Preclinical Neurological Studies - Review Article 23 January 2020 Pages: 125 - 130
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Makoto Naoi
Wakako Maruyama
Masayo Shamoto-Nagai
Neurology and Preclinical Neurological Studies - Review Article 28 January 2020 Pages: 131 - 147
Microglia and Parkinson's disease: footprints to pathology
Ekaterina Lazdon
Nofar Stolero
Dan Frenkel
Neurology and Preclinical Neurological Studies - Review Article 03 February 2020 Pages: 149 - 158
The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia
Dorit Ben-Shachar
Neurology and Preclinical Neurological Studies - Review Article 17 December 2019 Pages: 159 - 168
The catecholaldehyde hypothesis: where MAO fits in
David S. Goldstein
Neurology and Preclinical Neurological Studies - Review Article 05 December 2019 Pages: 169 - 177
Correction to: The catecholaldehyde hypothesis: where MAO fits in
David S. Goldstein
Correction 21 December 2019 Pages: 179 - 179
Parkinson’s disease and iron
Hideki Mochizuki
Chi-Jing Choong
Kousuke Baba
Neurology and Preclinical Neurological Studies - Review Article 05 February 2020 Pages: 181 - 187
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
David Devos
Z. Ioav Cabantchik
The FAIRPARK-II and FAIRALS-II studygroups
Neurology and Preclinical Neurological Studies - Review Article 07 January 2020 Pages: 189 - 203
Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy
Micaela Johanna Glat
Nadia Stefanova
Daniel Offen
Neurology and Preclinical Neurological Studies - Original Article 17 February 2020 Pages: 205 - 212
6-Hydroxydopamine: a far from simple neurotoxin
Damir Varešlija
Keith F. Tipton
Andrew G. McDonald
Neurology and Preclinical Neurological Studies - Original Article 01 January 2020 Pages: 213 - 230
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
Jelena Osmanovic Barilar
Ana Knezovic
Melita Salkovic-Petrisic
Neurology and Preclinical Neurological Studies - Review Article Open access 06 February 2020 Pages: 231 - 250
Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
Oxana Kapitansky
Eliezer Giladi
Illana Gozes
Neurology and Preclinical Neurological Studies - Original Article Open access 18 February 2020 Pages: 251 - 263
Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson’s disease
Thomas Müller
Ali Harati
Neurology and Preclinical Neurological Studies - Original Article 01 February 2020 Pages: 265 - 272
Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?
Toshiharu Nagatsu
Psychiatry and Preclinical Psychiatric Studies - Review Article 05 December 2019 Pages: 273 - 276
Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?
Toshiharu Nagatsu
Correction 28 January 2020 Pages: 277 - 277
Cannabinoid₁ (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Phil Skolnick
Roger Crystal
Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 31 December 2019 Pages: 279 - 286
FG 7142: is this validated tool to study anxiety now forgotten?
R. Horowski
Psychiatry and Preclinical Psychiatric Studies - SHORT COMMUNICATION 11 January 2020 Pages: 287 - 289
A platinum black-modified microelectrode for in situ olanzapine detection in microliter volumes of undiluted serum
Rajendra P. Shukla
Robert H. Belmaker
Hadar Ben-Yoav
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 06 January 2020 Pages: 291 - 299

Volume 127, Issue 2

Search

Navigation